Skip to the page

Data / Drug companies / Aphena Pharma Solutions - Tennessee, LLC

Aphena Pharma Solutions - Tennessee, LLC: 670 products in the FDA NDC directory, labeler code 71610

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Aphena Pharma Solutions - Tennessee, LLC (labeler code 71610) lists 670 products in the FDA National Drug Code Directory, covering 164 finished drugs by generic name. By type: 647 prescription drugs, 23 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on December 10, 2025.

The request: Watch Aphena Pharma Solutions - Tennessee, LLC (FDA labeler code 71610): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
71610
Products in commercial distribution
670
Packages
2,433
Finished drugs by generic name
164
Prescription products
647
Over the counter products
23
Controlled substance products
Schedule IV 58, Schedule V 43
Started marketing in the last 12 months
7
Earliest marketing start
September 1, 1972
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)62693.4%
New drug applications (NDA)182.7%
Over the counter monograph drugs152.2%
Authorized generics (NDA)101.5%
Other unapproved drugs10.1%

Products by type

TypeProductsShare
Prescription drugs64796.6%
Over the counter drugs233.4%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Pregabalin4154
Gabapentin2691
Metformin hydrochloride2179
Buspirone hydrochloride2050
Ibuprofen19190
Amlodipine besylate1649
Zolpidem tartrate1438
Lorazepam1438
Lisinopril1340
Terazosin hydrochloride1115
Clonazepam1036
Omeprazole10106
Metoprolol tartrate946
Tadalafil954
Simvastatin932
Rosuvastatin calcium934
Sacubitril and valsartan929
Potassium chloride984
Divalproex sodium848
Meloxicam854
Allopurinol854
Mirtazapine842
Losartan potassium843
Bupropion hydrochloride867
Trazodone hydrochloride839
Furosemide763
Atorvastatin calcium759
Amitriptyline hydrochloride735
Doxazosin728
Duloxetine hydrochloride618
Baclofen665
Etodolac631
Folic acid634
Nifedipine638
Carvedilol535
Sotalol hydrochloride525
Spironolactone545
Naproxen558
Prazosin hydrochloride535
Methocarbamol567
Quetiapine fumarate533
Metoprolol succinate546
Modafinil525
Tizanidine438
Warfarin410
Warfarin sodium416
Triamterene and hydrochlorothiazide427
Tamsulosin hydrochloride438
Memantine hydrochloride436
Hydroxychloroquine sulfate433
Temazepam428
Hydroxyzine hydrochloride451
Alprazolam437
Hydroxyzine pamoate430
Loperamide hydrochloride482
Lisinopril and hydrochlorothiazide tablets412
Chlorthalidone442
Topiramate456
Hydrochlorothiazide451
Pravastatin sodium439
Glipizide439
Rosuvastatin419
Gemfibrozil429
Oxybutynin chloride345
Citalopram331
Primidone323
Isosorbide mononitrate325
Risperidone343
Simethicone386
Atenolol336
Duloxetine336
Hydralazine hydrochloride347
Sertraline hydrochloride355
Cyclobenzaprine hydrochloride361
Cetirizine hydrochloride3119
Doxazosin mesylate312
Ticagrelor332
Ciprofloxacin hydrochloride236
Dicyclomine hydrochloride250
Guaifenesin2123
Finasteride231
Calcitriol223
Carbidopa and levodopa241
Fluoxetine hydrochloride244
Carisoprodol228
Cilostazol210
Naltrexone hydrochloride224
Magnesium oxide213
Propranolol hydrochloride251
Ergocalciferol219
Diphenoxylate hydrochloride and atropine sulfate222
Sertraline213
Lisinopril and hydrochlorothiazide221
Famotidine2138
Apixaban28
Fexofenadine hcl239
Ranolazine230
Verapamil hydrochloride246
Alogliptin25
Febuxostat222

Dosage forms

Dosage formProductsShare
Tablet32047.8%
Tablet, film coated15723.4%
Capsule10415.5%
Tablet, extended release345.1%
Tablet, film coated, extended release192.8%
Capsule, delayed release142.1%
Tablet, delayed release60.9%
Capsule, delayed release pellets50.7%
Tablet, chewable50.7%
Capsule, liquid filled30.4%
Capsule, extended release20.3%
Tablet, coated10.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Pregabalin71610-999CapsuleGeneric drugs (ANDA)December 10, 2025
Pregabalin71610-998CapsuleGeneric drugs (ANDA)December 10, 2025
Pregabalin71610-997CapsuleGeneric drugs (ANDA)December 10, 2025
Pregabalin71610-996CapsuleGeneric drugs (ANDA)December 10, 2025
Pregabalin71610-995CapsuleGeneric drugs (ANDA)December 10, 2025
Pregabalin71610-994CapsuleGeneric drugs (ANDA)December 10, 2025
Pregabalin71610-993CapsuleGeneric drugs (ANDA)December 10, 2025
Sacubitril and Valsartan71610-984TabletGeneric drugs (ANDA)September 30, 2025
Sacubitril and Valsartan71610-983TabletGeneric drugs (ANDA)September 30, 2025
Sacubitril and Valsartan71610-982TabletGeneric drugs (ANDA)September 30, 2025
Ibuprofen71610-969TabletGeneric drugs (ANDA)September 26, 2025
Ibuprofen71610-968TabletGeneric drugs (ANDA)September 26, 2025
Ibuprofen71610-967TabletGeneric drugs (ANDA)September 26, 2025
Doxazosin mesylate71610-965TabletAuthorized generics (NDA)September 24, 2025
Buspirone hydrochloride71610-975TabletGeneric drugs (ANDA)September 18, 2025
Buspirone hydrochloride71610-962TabletGeneric drugs (ANDA)September 18, 2025
Buspirone hydrochloride71610-959TabletGeneric drugs (ANDA)September 18, 2025
Potassium Chloride71610-977Tablet, extended releaseGeneric drugs (ANDA)August 8, 2025
Ranolazine71610-971Tablet, film coated, extended releaseGeneric drugs (ANDA)June 30, 2025
Ticagrelor71610-914Tablet, film coatedGeneric drugs (ANDA)May 7, 2025
Ticagrelor71610-958TabletGeneric drugs (ANDA)May 1, 2025
Cyclobenzaprine Hydrochloride71610-933TabletGeneric drugs (ANDA)April 10, 2025
Fexofenadine hcl71610-905Tablet, film coatedGeneric drugs (ANDA)March 10, 2025
Bupropion Hydrochloride71610-899TabletGeneric drugs (ANDA)January 30, 2025
Sacubitril and Valsartan71610-955Tablet, film coatedGeneric drugs (ANDA)January 21, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.